(Q32014676)

English

Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

C J Poole

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

T Perren

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

A Burton

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

S D Jordan

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

A H Jenkins

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

J J Mould

6

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

D A Spooner

7

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

D Luesley

8

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

K K Chan

9

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

S Sturman

10

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

H M Earl

11

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1603-1608

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of small cell lung cancer: a summary of the Third International Association for the Study of Lung Cancer Workshop on Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Platinum resistance: laboratory findings and clinical implications

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008343519687

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008343519687

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32014676&oldid=1909610749"